Product Code: ANV1760
REPORT HIGHLIGHT
Baculovirus Expression System Market size was valued at USD 350.7 Million in 2022, expanding at a CAGR of 9.2% from 2023 to 2030.
The baculovirus expression system has been widely employed in the expression of recombinant proteins within insect cells for many years. Recombinant Baculovirus vectors for temporary and stable gene delivery into various mammalian cell lines have recently been developed. The Baculovirus Expression System is a potent and adaptable platform for producing recombinant proteins, particularly those that require specific post-translational modifications. Its powers go beyond just protein expression, with potential medicinal applications as well.
Baculovirus Expression System Market- Market Dynamics
The high prevalence of lifestyle diseases is expected to propel market demand
There has been a rise in research into novel proteins, enzymes, and other compounds that can act as possible treatments or diagnostics for lifestyle disorders. This necessitates systems capable of producing these proteins in their active forms, in adequate quantities, and with the necessary post-translational modifications. Lifestyle diseases, often known as non-communicable diseases (NCDs), include cardiovascular disease, diabetes, obesity, and some malignancies. Because of this spike, there is an urgent need for novel and effective therapeutic methods.
According to the World Health Organization, each year, 17 million people die from non-communicable diseases before age 70; 86% of these premature deaths occur in low- and middle-income countries. As baculoviruses are being researched for possible applications in gene therapy, any breakthroughs could open up new business opportunities for BES. However, The BES process, which involves recombination, virus amplification, and protein harvesting, can be complex and lengthy, which may discourage some potential users.
Baculovirus Expression System Market- Key Insights
- As per the analysis shared by our research analyst, the global Baculovirus Expression System market is estimated to grow annually at a CAGR of around 9.2% over the forecast period (2023-2030)
- The Baculovirus Expression System industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on Application segmentation, Therapeutic was predicted to show maximum market share in the year 2022
- Based on End-User segmentation, pharmaceutical and Biotechnology was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Baculovirus Expression System Market- Segmentation Analysis:
The Global Baculovirus Expression System Market is segmented on the basis of Application, End-User, and Region.
The market is divided into three categories based on Application: Therapeutic, Research, and Industrial. The therapeutic segment dominates the market. The BES's capacity to introduce mammalian-like post-translational modifications has made it a favored alternative for therapeutic protein synthesis. To be useful and safe in therapeutic applications, these proteins frequently require specialized changes.
The market is divided into two categories based on End-User: Pharmaceutical and Biotechnology companies, Contract research organizations, contract manufacturing organizations, Academic research institutes, and Others. pharmaceutical and Biotechnology companies dominate the market growth. They utilize BES for drug discovery, vaccine development, and the manufacture of therapeutic proteins. Given the size of their operations and the commercial relevance of the products they manufacture; they account for a sizable amount of market demand.
Baculovirus Expression System Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market due to the high growth of the pharmaceutical and biotechnological sectors. U.S. pharmaceutical and biotech companies are among the top global spenders on research and development. This investment drives the demand for effective protein expression platforms, including BES. According to pharmaceutical industry statistics, The U.S. is expected to spend USD605-USD635 billion on medicine in 2025. And there are more than 310,574 pharmacists currently employed in the United States. Europe is expected to second largest region for the growth of this market, due to increasing funding for protein research.
Baculovirus Expression System Market- Competitive Landscape:
The Baculovirus Expression System (BES) market has a diverse set of players offering products, services, and solutions suited to the BES. These players compete on the basis of product quality, innovation, pricing, and after-sales services. Companies are constantly striving to increase the efficiency of their BES products in order to achieve higher yields and better protein quality. Companies are striving to expand their reach as a biotechnology research and use develop globally, particularly in emerging areas where demand is expanding. For example, Merck provides tools and services related to the BES. Their offerings include kits, reagents, and services tailored for maximum protein yield and quality.
Recent Developments:
On May 2, 2018, Historically, undefined insect media components such as yeast late have made it challenging to achieve consistent results and protein yields across multiple experiments. These factors can significantly slow vaccine development at a time when manufacturers are under pressure to develop vaccines faster and more efficiently. Focused on removing barriers to vaccine development and production, Thermo Fisher Scientific announced today its Gibco ExpiSf system, the first-ever chemically defined insect protein expression system.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET KEY PLAYERS
- Thermo Fisher Scientific Inc
- Promega corporation
- New England Biolabs
- Merck Millipore
- Genscript USA Inc
- Clontech Laboratories
GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY APPLICATION
- Therapeutic
- Research
- Industrial
GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY END-USER
- Pharmaceutical and Biotechnology companies
- Contract research organizations
- contract manufacturing organization
- Academic research institutes
- Others
GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY REGION
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Baculovirus Expression System Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Baculovirus Expression System Market Snippet by Application
- 2.1.2. Baculovirus Expression System Market Snippet by End-User
- 2.1.3. Baculovirus Expression System Market Snippet by Country
- 2.1.4. Baculovirus Expression System Market Snippet by Region
- 2.2. Competitive Insights
3. Baculovirus Expression System Key Market Trends
- 3.1. Baculovirus Expression System Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Baculovirus Expression System Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Baculovirus Expression System Market Opportunities
- 3.4. Baculovirus Expression System Market Future Trends
4. Baculovirus Expression System Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Baculovirus Expression System Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Baculovirus Expression System Market Landscape
- 6.1. Baculovirus Expression System Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Baculovirus Expression System Market - By Application
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 7.1.1.1. Therapeutic
- 7.1.1.2. Research
- 7.1.1.3. Industrial
8. Baculovirus Expression System Market - By End-User
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
- 8.1.1.1. Pharmaceutical and Biotechnology companies
- 8.1.1.2. Contract research organizations
- 8.1.1.3. Contract Manufacturing Organization
- 8.1.1.4. Academic research institutes
- 8.1.1.5. Others
9. Baculovirus Expression System Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Baculovirus Expression System Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Baculovirus Expression System Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Baculovirus Expression System Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Baculovirus Expression System Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Baculovirus Expression System Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Baculovirus Expression System Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Thermo Fisher Scientific Inc
- 10.2.2. Promega corporation
- 10.2.3. New England Biolabs
- 10.2.4. Merck Millipore
- 10.2.5. Genscript USA Inc
- 10.2.6. Clontech Laboratories
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us